MYC and osteosarcoma: In contrast, it was shown that c-myc was negatively regulated by miR-33 at the post-transcriptional level, via a specific target site within the 3’UTR and over-expression of c-myc impaired miR-33b-induced inhibition of proliferation and invasion in osteosarcoma cells [16].